-
1
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Blonch DA, et al. 1988. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum, 31:315-24.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Blonch, D.A.3
-
2
-
-
0034469156
-
A revival of the B-cell paradigm for rheumatoid arthritis pathogenesis
-
Benoist C and Mathis D. 2000. A revival of the B-cell paradigm for rheumatoid arthritis pathogenesis. Arthritis Res, 2:90-4.
-
(2000)
Arthritis Res
, vol.2
, pp. 90-94
-
-
Benoist, C.1
Mathis, D.2
-
3
-
-
0027220101
-
Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients
-
Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM, et al. 1993. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann Rheum Dis, 52:517-9.
-
(1993)
Ann Rheum Dis
, vol.52
, pp. 517-519
-
-
Boki, K.A.1
Drosos, A.A.2
Tzioufas, A.G.3
Lanchbury, J.S.4
Panayi, G.S.5
Moutsopoulos, H.M.6
-
4
-
-
0026718786
-
HLA Class II sequence polymorphisms and susceptibility to RA in Greeks
-
Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS, et al. 1992. HLA Class II sequence polymorphisms and susceptibility to RA in Greeks. Arthritis Rheum, 35:749-55.
-
(1992)
Arthritis Rheum
, vol.35
, pp. 749-755
-
-
Boki, K.A.1
Panayi, G.S.2
Vaughan, R.W.3
Drosos, A.A.4
Moutsopoulos, H.M.5
Lanchbury, J.S.6
-
5
-
-
33746961890
-
Efficasy and safety of rituximab in active rheumatoid arthritis patients who experienced an inadequate response to one or more anti-TNF therapies (REFLEX study)
-
Conen S, Emery P, Greenwald M, et al. 2006. Efficasy and safety of rituximab in active rheumatoid arthritis patients who experienced an inadequate response to one or more anti-TNF therapies (REFLEX study). Arthritis Rheum, 54:2793-806.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2793-2806
-
-
Conen, S.1
Emery, P.2
Greenwald, M.3
-
6
-
-
0036676817
-
Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: Evidence for a pathogenic role of B-cells
-
De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G, et al. 2002. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenic role of B-cells. Arthritis Rheum, 46:2029-33.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2029-2033
-
-
de Vita, S.1
Zaja, F.2
Sacco, S.3
de Candia, A.4
Fanin, R.5
Ferraccioli, G.6
-
7
-
-
0037732689
-
The role of B cells in rheumatoid arthritis: Mechanisms and therapeutic targets
-
Dorner T and Burmeister GR. 2003. The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol, 15:246-52.
-
(2003)
Curr Opin Rheumatol
, vol.15
, pp. 246-252
-
-
Dorner, T.1
Burmeister, G.R.2
-
8
-
-
0026769393
-
Rheumatoid arthritis in Greek and British patients, a comparative clinical, radiological and serologic study
-
Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM, et al. 1992. Rheumatoid arthritis in Greek and British patients, a comparative clinical, radiological and serologic study. Arthritis Rheum, 35:745-8.
-
(1992)
Arthritis Rheum
, vol.35
, pp. 745-748
-
-
Drosos, A.A.1
Lanchbury, J.S.2
Panayi, G.S.3
Moutsopoulos, H.M.4
-
9
-
-
0029113092
-
Reumatoid arthritis in Greece: Clinical, serological and genetic considerations
-
Drosos AA and Moutsopoulos HM. 1995. Reumatoid arthritis in Greece: clinical, serological and genetic considerations. Clin Exp Rheumatol, 13(Suppl 12):S7-12.
-
(1995)
Clin Exp Rheumatol
, vol.13
, Issue.SUPPL. 12
-
-
Drosos, A.A.1
Moutsopoulos, H.M.2
-
10
-
-
0033033201
-
Do selfperpetueting B lymphocytes drive human autoimmune disease?
-
Edwards JCW, Cambridge G, Abrahams VM, et al. 1999. Do selfperpetueting B lymphocytes drive human autoimmune disease? Immunology, 97:188-96.
-
(1999)
Immunology
, vol.97
, pp. 188-196
-
-
Edwards, J.C.W.1
Cambridge, G.2
Abrahams, V.M.3
-
11
-
-
0035093233
-
Sustained improvement on rheumatoid arthritis following a protocol designed to deplete B lympocytes
-
Edwards JCW and Cambridge G. 2001. Sustained improvement on rheumatoid arthritis following a protocol designed to deplete B lympocytes. Rheumatology, 40:205-11.
-
(2001)
Rheumatology
, vol.40
, pp. 205-211
-
-
Edwards, J.C.W.1
Cambridge, G.2
-
12
-
-
2942537697
-
Efficasy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis
-
Edwards JCW, Szczepanski L, Szechinski J, et al. 2004. Efficasy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med, 350:2572-81.
-
(2004)
N Engl J Med
, vol.350
, pp. 2572-2581
-
-
Edwards, J.C.W.1
Szczepanski, L.2
Szechinski, J.3
-
13
-
-
19944433874
-
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
-
Feltelius N, Fored CM, Blomqvist P, et al. 2005. Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept. Ann Rheum Dis, 64:246-52.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 246-252
-
-
Feltelius, N.1
Fored, C.M.2
Blomqvist, P.3
-
14
-
-
47349108026
-
Infusion-associated events decrease with repeat courses of rituximab in patients with active rheumatoid arthritis
-
Fleischmann, Van Vollenhoven R, Udell J, et al. 2006. Infusion-associated events decrease with repeat courses of rituximab in patients with active rheumatoid arthritis. Arthritis Rheum, 54(Suppl):S238.
-
(2006)
Arthritis Rheum
, vol.54
, Issue.SUPPL.
-
-
Fleischmann1
van Vollenhoven, R.2
Udell, J.3
-
15
-
-
0035050214
-
Role of B-cells in the pathogenesis of rheumatoid arthritis: Potential implication of treatment
-
Gause A, Berek C. Role of B-cells in the pathogenesis of rheumatoid arthritis: potential implication of treatment. Bio-Drugs, 2001;15:73-9.
-
(2001)
Bio-Drugs
, vol.15
, pp. 73-79
-
-
Gause, A.1
Berek, C.2
-
17
-
-
34447329384
-
Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to one or more TNF inhibitors
-
Keystone E, Fleischmann RM, Emery P, et al. 2006. Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to one or more TNF inhibitors. Arthritis Rheum, (54 Suppl):S328.
-
(2006)
Arthritis Rheum
, Issue.54 SUPPL.
-
-
Keystone, E.1
Fleischmann, R.M.2
Emery, P.3
-
18
-
-
1042290332
-
Once-weekly administration of 50 mf of etanrecept in patients with active RA: Results of a multicenter, randomized, double-blind, placebo-controlled trial
-
Keystone EC, Schiff MH, Kremer JM, et al. 2004. Once-weekly administration of 50 mf of etanrecept in patients with active RA: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum, 50:353-63.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 353-363
-
-
Keystone, E.C.1
Schiff, M.H.2
Kremer, J.M.3
-
19
-
-
0034469424
-
B-cells in rheumatoid arthritis
-
Kim HJ and Berek C. 2000. B-cells in rheumatoid arthritis. Arthritis Res, 2:126-31.
-
(2000)
Arthritis Res
, vol.2
, pp. 126-131
-
-
Kim, H.J.1
Berek, C.2
-
20
-
-
0037129969
-
Rheumatoid arthritis-a molecular understanding
-
Lawrence JB and Haynes MK. 2002. Rheumatoid arthritis-a molecular understanding. Ann Intern Med, 136:908-22.
-
(2002)
Ann Intern Med
, vol.136
, pp. 908-922
-
-
Lawrence, J.B.1
Haynes, M.K.2
-
21
-
-
0031968825
-
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
-
Lawrence RC, Helmick CG, Arnett FC, et al. 1998. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum, 41:778-9.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 778-779
-
-
Lawrence, R.C.1
Helmick, C.G.2
Arnett, F.C.3
-
22
-
-
0034735842
-
Infliximab and methotrexate in the treatment of rheumatoid arthritis
-
Lipsky PE, Van der Heijde DM, St Clair EW, et al. 2000. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med, 343:1594-602.
-
(2000)
N Engl J Med
, vol.343
, pp. 1594-1602
-
-
Lipsky, P.E.1
van der Heijde, D.M.2
St Clair, E.W.3
-
23
-
-
24944472774
-
B-cells: A fundamental role in the pathogenesis of rheumatoid arthritis?
-
Panagyi GS. 2005. B-cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology (Oxford), 44(Suppl 2):ii3-ii7.
-
(2005)
Rheumatology (Oxford)
, vol.44
, Issue.SUPPL. 2
-
-
Panagyi, G.S.1
-
24
-
-
0021212076
-
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
-
Pincus T, Callahan LF, Sale WG, et al. 1984. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum, 27:864-72.
-
(1984)
Arthritis Rheum
, vol.27
, pp. 864-872
-
-
Pincus, T.1
Callahan, L.F.2
Sale, W.G.3
-
25
-
-
0035463152
-
Presence of a population of CD20p, CD38-B lymphocytes with defective proliferative responsivness in the synovial compartment of patients with rheumatoid arthritis
-
Reparon-Schuijt CC, Van Esch WJ, Van Kooten C, et al. 2001. Presence of a population of CD20p, CD38-B lymphocytes with defective proliferative responsivness in the synovial compartment of patients with rheumatoid arthritis. Arthritis Rheum, 44:2029-37.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2029-2037
-
-
Reparon-Schuijt, C.C.1
van Esch, W.J.2
van Kooten, C.3
-
26
-
-
0034473683
-
Epidemiology of rheumatic diseases
-
Sangha O. 2001. Epidemiology of rheumatic diseases. Rheumatology (Oxford), 39(Suppl):3-12.
-
(2001)
Rheumatology (Oxford)
, vol.39
, Issue.SUPPL.
, pp. 3-12
-
-
Sangha, O.1
-
27
-
-
0037255527
-
Clonal analysis of B cells in the synovial membrane of patients with rheumatoid arthritis
-
Shiokawa S, Matsumoto N, Nishimura J, et al. 2003. Clonal analysis of B cells in the synovial membrane of patients with rheumatoid arthritis. Scand J Rheumatol, 32:12-8.
-
(2003)
Scand J Rheumatol
, vol.32
, pp. 12-18
-
-
Shiokawa, S.1
Matsumoto, N.2
Nishimura, J.3
-
28
-
-
0035888030
-
T-cell activation in rheumatoid synovium is B-cell dependent
-
Takemura S, Klimiuk PA, Braun A, et al. 2001. T-cell activation in rheumatoid synovium is B-cell dependent. J Immunol., 167:4710-8.
-
(2001)
J Immunol.
, vol.167
, pp. 4710-4718
-
-
Takemura, S.1
Klimiuk, P.A.2
Braun, A.3
-
29
-
-
0141923537
-
B lymphocytes contribute to autoimmune disease pathogenesis: Current trends and clinical implications
-
Tuscano JM, Harris GS, Tedder TF, et al. 2003. B lymphocytes contribute to autoimmune disease pathogenesis:current trends and clinical implications. Autoimmun Rev, 2:101-8.
-
(2003)
Autoimmun Rev
, vol.2
, pp. 101-108
-
-
Tuscano, J.M.1
Harris, G.S.2
Tedder, T.F.3
-
30
-
-
0037231533
-
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
-
Weinblatt ME, Keystone EC, Furst DE, et al. 2003. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum, 48:35-45.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 35-45
-
-
Weinblatt, M.E.1
Keystone, E.C.2
Furst, D.E.3
-
31
-
-
0035001641
-
Pathogenesis of rheumatoid arthritis. Role of B lymphocytes
-
Zhang Z and Bridges SL. 2001. Pathogenesis of rheumatoid arthritis. Role of B lymphocytes. Rheum Disease Clin North Am, 27:335-53.
-
(2001)
Rheum Disease Clin North Am
, vol.27
, pp. 335-353
-
-
Zhang, Z.1
Bridges, S.L.2
|